Abstract
Publication details
- DOI
- 10.4103/0974-620x.53042
- Journal
- Oman Journal of Ophthalmology, 2(2), 94-95
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Deka, S., Kalita, K., & Singh, S. K. (2009). Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion. Oman Journal of Ophthalmology, 2(2), 94-95. https://doi.org/10.4103/0974-620x.53042
MLA 9
Deka, Satyen, et al. "Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion." Oman Journal of Ophthalmology, vol. 2, no. 2, 2009, pp. 94-95. https://doi.org/10.4103/0974-620x.53042.
Chicago (author–date)
Deka, Satyen, Kruto Kalita, and Sunil Kumar Singh. 2009. "Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion." Oman Journal of Ophthalmology 2 (2): 94-95. https://doi.org/10.4103/0974-620x.53042.
Harvard
Deka, S., Kalita, K. and Singh, S. K. (2009) 'Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion', Oman Journal of Ophthalmology, 2(2), pp. 94-95. doi:10.4103/0974-620x.53042.
Vancouver
Deka S, Kalita K, Singh SK. Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion. Oman Journal of Ophthalmology. 2009;2(2):94-95. doi:10.4103/0974-620x.53042
IEEE
S. Deka, K. Kalita, and S. K. Singh, "Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion," Oman Journal of Ophthalmology, vol. 2, no. 2, pp. 94-95, 2009, doi: 10.4103/0974-620x.53042.